Plasma and cerebrospinal fluid neurofilament light protein concentrations are differentially associated with biomarker evidence of neurodegeneration in a community‐based population of 70‐year‐olds
Anna Dittrich(Sahlgrenska University Hospital), Silke Kern(University of Gothenburg), Anna Zettergren(University of Gothenburg), Ingmar Skoog(Sahlgrenska University Hospital), Michael Schöll(Wallenberg Wood Science Center), Henrik Zetterberg(University of Wisconsin–Madison), Eric Westman(Wellcome Centre for Human Neuroimaging), Joel Simrén(University of Gothenburg), Nicholas J. Ashton(King's College London), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k